Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-15 4:18 pm Purchase | 13G | NEKTAR THERAPEUTICS NKTR | TCG Crossover GP II LLC | 20,046,350 9.9% | 20,046,350 (New Position) | View |
| 2024-02-14 5:03 pm Sale | 13G | NEKTAR THERAPEUTICS NKTR | RA CAPITAL MANAGEMENT L.P. | 0 0% | -18,700,000 (Position Closed) | View |
| 2024-02-14 4:58 pm Sale | 13G | NEKTAR THERAPEUTICS NKTR | CITADEL ADVISORS LLC | 5,635,132 3% | -4,094,620 (-42.08%) | View |
| 2024-02-14 08:50 am Purchase | 13G | NEKTAR THERAPEUTICS NKTR | Deep Track Capital LP | 18,400,000 9.65% | 6,097,763 (+49.57%) | View |
| 2024-02-13 5:09 pm Sale | 13G | NEKTAR THERAPEUTICS NKTR | VANGUARD GROUP INC | 12,042,873 6.31% | -13,314 (-0.11%) | View |
| 2023-08-17 4:30 pm Purchase | 13G | NEKTAR THERAPEUTICS NKTR | RA CAPITAL MANAGEMENT L.P. | 18,700,000 9.8% | 18,700,000 (New Position) | View |
| 2023-07-10 2:09 pm Sale | 13G | NEKTAR THERAPEUTICS NKTR | Invesco Ltd. IVZ | 5,535,430 2.9% | -31,792,043 (-85.17%) | View |
| 2023-07-10 10:41 am Sale | 13G | NEKTAR THERAPEUTICS NKTR | VANGUARD GROUP INC | 12,056,187 6.37% | -11,009,588 (-47.73%) | View |
| 2023-07-07 4:35 pm Sale | 13G | NEKTAR THERAPEUTICS NKTR | BlackRock Inc. BLK | 8,604,322 4.5% | -9,696,352 (-52.98%) | View |
| 2023-07-07 1:28 pm Sale | 13G | NEKTAR THERAPEUTICS NKTR | PRIMECAP MANAGEMENT CO | 8,149,876 4.31% | -7,509,177 (-47.95%) | View |
| 2023-07-03 4:02 pm Purchase | 13G | NEKTAR THERAPEUTICS NKTR | CITADEL ADVISORS LLC | 9,729,752 5.1% | 9,729,752 (New Position) | View |
| 2023-05-05 11:52 am Sale | 13G | NEKTAR THERAPEUTICS NKTR | BlackRock Inc. BLK | 18,300,674 9.7% | -17,627,419 (-49.06%) | View |
| 2023-04-14 4:34 pm Purchase | 13G | NEKTAR THERAPEUTICS NKTR | Deep Track Capital LP | 12,302,237 6.5% | 12,302,237 (New Position) | View |
| 2023-02-09 4:01 pm Sale | 13G | NEKTAR THERAPEUTICS NKTR | PRIMECAP MANAGEMENT CO | 15,659,053 8.33% | -1,753,369 (-10.07%) | View |
| 2023-02-09 11:27 am Purchase | 13G | NEKTAR THERAPEUTICS NKTR | VANGUARD GROUP INC | 23,065,775 12.27% | 4,553,864 (+24.60%) | View |
| 2023-02-06 3:02 pm Sale | 13G | NEKTAR THERAPEUTICS NKTR | WELLINGTON MANAGEMENT GROUP LLP | 0 0% | -11,383,721 (Position Closed) | View |
| 2023-02-02 3:19 pm Purchase | 13G | NEKTAR THERAPEUTICS NKTR | Invesco Ltd. IVZ | 37,327,473 19.9% | 435,979 (+1.18%) | View |
| 2023-01-23 3:52 pm Purchase | 13G | NEKTAR THERAPEUTICS NKTR | BlackRock Inc. BLK | 35,928,093 19.1% | 9,256,290 (+34.70%) | View |
| 2022-02-11 12:22 pm Purchase | 13G | NEKTAR THERAPEUTICS NKTR | Invesco Ltd. IVZ | 36,891,494 20% | 1,434,545 (+4.05%) | View |
| 2022-02-10 12:26 pm Sale | 13G | NEKTAR THERAPEUTICS NKTR | PRIMECAP MANAGEMENT CO | 17,412,422 9.43% | -1,027,977 (-5.57%) | View |